Research programme: endoglin antibodies - TraconAlternative Names: TRC 205
Latest Information Update: 17 Feb 2016
At a glance
- Originator TRACON Pharmaceuticals
- Class Monoclonal antibodies
- Mechanism of Action ENG protein inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Fibrosis
Most Recent Events
- 25 Jan 2016 Preclinical trials in Fibrosis in USA (Parenteral)